CRBU
Caribou Biosciences Inc
NASDAQ: CRBU · HEALTHCARE · BIOTECHNOLOGY
$1.88
-2.08% today
Updated 2026-04-30
Market cap
$205.84M
P/E ratio
—
P/S ratio
18.45x
EPS (TTM)
$-1.59
Dividend yield
—
52W range
$1 – $4
Volume
1.4M
Caribou Biosciences Inc (CRBU) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-722.00%
ROE
-79.00%
ROA
-34.30%
Debt/equity
0.18x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $5.79M | $-23.43M | 100.00% | -592.69% | -404.82% |
| 2020 | $12.36M | $-34.31M | -178.50% | -292.24% | -277.55% |
| 2021 | $9.60M | $-66.92M | 89.75% | -697.84% | -697.26% |
| 2022 | $13.85M | $-99.42M | 73.71% | -768.17% | -717.79% |
| 2023 | $34.48M | $-102.07M | 89.78% | -336.63% | -296.05% |
| 2024 | $9.99M | $-149.10M | 60.71% | -1,667.16% | -1,491.95% |
| 2025 | $11.16M | $-148.13M | 67.34% | -1,220.49% | -1,327.40% |